Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
108.50    7.00 (6.90%)
Bid:
106.00
Ask:
111.00
Spread: 5.00 (4.717%)
Market Cap: £65.28m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

6 Nov 2017 13:58

RNS Number : 6759V
Intercede Group PLC
06 November 2017
Β 

Β 

6 November 2017

INTERCEDE GROUP plc

("Intercede", or the "Group")

Trading Update

Β 

Further to the trading update of 5 October 2017, Intercede has experienced a slower market than expected and a number of large enterprise awards anticipated for this quarter have so far failed to materialise in spite of customer commitments to the contrary. This suggests a tightening of fiscal controls inside the customer base over which Intercede has no control. While these orders are expected to be awarded eventually, customer delays are making accurate forecasting for the financial year extremely challenging.

Specifically, Intercede was informed in writing on 3 November 2017 that a significant order of over $2m from an existing customer that was forecast to be received in the current financial year ending 31 March 2018, will not now be raised until the first quarter of the next financial year. This deferral of sales revenue will have a material impact on the Group's ability to meet market expectations.

Intercede is now forecasting revenue growth for the current financial year in the range of 10%-20%. This is based on the timing of receipt of a small number of large orders and Intercede's subsequent ability to deliver and recognise revenues in accordance with the Group's accounting policy.

Existing customers are continuing to invest in MyID solutions and the renewal of support and maintenance contracts. Intercede is therefore receiving the full cash benefit of these renewals even though we can only recognise pro-rata revenues in the current year. In addition to an R&D tax credit of Β£1.1m, that was received in July 2017, this has resulted in cash balances of Β£4.2m as at 31 October 2017.

Richard Parris, Chairman and CEO, said, "the market has never been in more need of the solutions we provide, we have recently invested in a world-class sales team and we have migrated our platform to also operate in the Cloud on a subscription based model. We are poised for take-off in new mid-market enterprise and consumer oriented markets. Unfortunately, short term sales in our traditional markets have been disappointing and are challenging our plans for organic growth."

Β 

Contact

Intercede Group plc

Tel: +44 (0) 1455 558 111

Richard Parris

Chairman & Chief Executive

Andrew Walker

Finance Director

finnCap

Tel: +44 (0) 20 7220 0500

Stuart Andrews

Corporate Finance

Simon Hicks

Corporate Finance

Capital Access Group

Tel: +44 (0) 20 3763 3400

Scott Fulton

Media

Ed Welsby

Investors

Β 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. In 2016, Intercede launched RapID, a secure, easy to implement authentication service for mobile apps and cloud services to completely eliminate the need for passwords.

For more information visit: www.intercede.com

Β 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTFSLFDMFWSEIF
Date   Source Headline
30th Mar 20097:00 amRNSMaritime Credentialing Program Update
10th Mar 200910:21 amRNSAdditional Listing
5th Feb 20097:00 amRNSPositive Trading Update
12th Jan 20097:00 amRNSContract with BT for NHS Nat'l Data Spine
8th Jan 20097:00 amRNSIntercede Technology Used by Queensland Police
15th Dec 20089:45 amRNSDirector's Share Purchase
15th Dec 20087:00 amRNSNew Contract with Lockheed Martin
9th Dec 20087:00 amRNSInterim Results
4th Dec 20087:00 amRNSNew Contracts
25th Nov 20087:00 amRNSNew Reseller Agreement
17th Nov 20087:00 amRNSNew Reseller Partnership
22nd Oct 20087:00 amRNSRe: US Maritime Credentialing Program
6th Oct 20087:00 amRNSStatement Re ActivIdentity Patent Claim
6th Oct 20087:00 amRNSPositive Trading Update
29th Sep 20087:00 amRNSSubcontract With Lockheed Martin
17th Sep 200810:37 amRNSDirector/PDMR Shareholding
27th Aug 200810:26 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSAppointment of Global Sales D
25th Jul 20087:00 amRNSDirector/PDMR Shareholding
24th Jul 20087:00 amRNSTrading Update
30th May 20087:00 amRNSTotal Voting Rights
20th May 20087:00 amRNSFinal Results
14th May 20087:00 amRNSAdditional Listing
2nd May 200810:33 amRNSResponse to Press Speculation
11th Apr 20087:00 amRNSTrading Update
14th Feb 20087:00 amRNSTrading Update
17th Dec 200711:58 amRNSDirector Share Dealings
11th Dec 20077:01 amRNSInterim Results
3rd Oct 20077:00 amRNSTrading Update
6th Sep 20077:01 amRNSFurther Re Licence
30th Aug 20077:01 amRNSNew Licence Agreement
16th Aug 200710:01 amRNSAIM Rule 26
31st May 20077:00 amRNSTotal Voting Rights
25th May 20077:02 amRNSFinal Results
16th May 20077:01 amRNSPlacing
19th Apr 20075:25 pmRNSHolding(s) in Company
27th Mar 20077:02 amRNSTrading Update
19th Dec 200611:33 amRNSFurther US Government Win
18th Dec 20061:18 pmRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSInterim Results
8th Dec 200611:43 amRNSTotal Voting Rights
27th Nov 20067:31 amRNSRe Gemalto Partnership in US
23rd Nov 200611:16 amRNSFurther US Government Wins
20th Nov 20067:02 amRNSNew US Government Contracts
16th Nov 20067:03 amRNSNew US Government Contract
23rd Oct 20067:01 amRNSContract Update
9th Oct 20067:01 amRNSUS Government Contract Win
1st Jun 20067:01 amRNSPreliminary Results
31st Mar 200612:00 pmRNSDirectorate Change
31st Mar 20067:02 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.